COVID-PACT

COVID-PACT is a multicenter, randomized, open-label, 2 x 2 factorial design trial of full-dose anticoagulation vs. standard-dose prophylactic anticoagulation and antiplatelet therapy vs. no antiplatelet therapy on the risk of venous or arterial thrombotic events in ICU patients with COVID-19.  Study patients will be followed until their 28th day or hospital discharge, whichever comes first.

Diagram for Kate

COVID-PACT on ClinicalTrials.gov

CONTACT US about COVID-PACT

%d bloggers like this:
search previous next tag category expand menu location phone mail time cart zoom edit close